株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

先進創傷ケアのトップ20社の分析:2020年

Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies

発行 Visiongain Ltd 商品コード 915073
出版日 ページ情報 英文 129 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=147.19円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

Back to Top
先進創傷ケアのトップ20社の分析:2020年 Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies
出版日: 2019年09月30日 ページ情報: 英文 129 Pages
概要

2018年における世界の先進創傷ケアの市場は92億ドルと推計されています。

当レポートでは、世界の先進創傷ケアの市場を調査し、市場の定義と概要、地域別の需要動向、市場成長への各種影響因子の分析、主要20社のランキング、主要20社の財務的展望、製品ポートフォリオ、戦略的展開などの分析をまとめています。

第1章 レポート概要

第2章 イントロダクション:先進創傷ケア市場

  • 市場の定義
  • 市場区分
    • 治療区分
      • 従来型ケア
      • 先進創傷ケア
    • 皮膚補充
      • スキンリプレイスメント治療
      • コラーゲン治療
      • 細胞治療
    • デバイス
      • 陰圧創傷治療 (NPWT)
      • 超音波
  • 地域需要
    • 南北アメリカ
    • 欧州
    • アジア太平洋

第3章 世界の先進創傷ケア市場

  • 市場概要
  • 産業動向・予測
  • 成長推進因子・課題・市場機会

第4章 主要20社の位置付け

  • 企業ランキング
  • 世界の先進創傷ケア市場の予測

第5章 トップ20社

  • Smith & Nephew Plc.
  • Acelity (KCI and Systagenix)
  • Molnlycke Health Care AB
  • ConvaTec Group Plc
  • Coloplast A/S
  • 3M Company
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Generex Biotechnology Corp.
  • Hill-Rom Holdings, Inc.
  • Hollister, Inc.
  • Integra LifeSciences Holdings Corporation
  • Lohmann & Rauscher GmbH & Co. Kg
  • Medline Industries, Inc.
  • Medtronic PLC
  • Organogenesis Inc.
  • PAUL HARTMANN AG
  • Celularity, Inc.
  • Johnson & Johnson

第6章 SWOT分析

第7章 総論

  • 継続的イノベーション・強力なR&Dパイプライン
  • 他の治療薬と比較した高効率性
  • 寡占市場
  • トップ20社と収益

付録

図表

List of Tables

  • Table 2.1 The Global Advanced Wound Care Market Revenue Forecast ($bn), 2018-2029
  • Table 2.2 The North America Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 2.3 The Europe Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 2.4 Asia-pacific Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 4.1 Companies Profiled in this Report and Country HQ
  • Table 4.2 Global Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 5.1 Smith & Nephew Plc.: Key Facts, 2019
  • Table 5.2 Smith & Nephew Plc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.3 Smith & Nephew Plc.: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.4 Smith & Nephew Plc.: Advanced Wound Management Revenue ($million), AGR (%) 2016-2018
  • Table 5.5 Smith & Nephew Plc.: Advanced Wound Management Product Revenue ($million) and Revenue Shares (%), 2018
  • Table 5.6 Smith & Nephew Plc.: Strategic Developments, 2015-2019
  • Table 5.7 Acelity L.P. Inc.: Key Facts, 2019
  • Table 5.8 Acelity L.P. Inc.: Strategic Developments, 2015-2019
  • Table 5.9 Mölnlycke: Key Facts, 2019
  • Table 5.10 Mölnlycke: Strategic Developments, 2015-2019
  • Table 5.11 ConvaTec Group Plc: Key Facts, 2019
  • Table 5.12 ConvaTec Group Plc: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.13 ConvaTec Group Plc: Advanced Wound Care Revenue ($million), AGR (%) 2016-2018
  • Table 5.14 ConvaTec Group Plc: Strategic Developments, 2015-2019
  • Table 5.15 Coloplast A/S: Key Facts, 2018
  • Table 5.16 Coloplast A/S: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.17 Coloplast A/S: Wound & Skin Care Revenue ($million), AGR (%) 2016-2018
  • Table 5.18 Coloplast A/S: Strategic Developments, 2015-2019
  • Table 5.19 3M Company: Key Facts, 2019
  • Table 5.20 3M Company: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.21 3M Company: Strategic Developments, 2015-2018
  • Table 5.22 B. Braun Melsungen AG: Key Facts, 2019
  • Table 5.23 B. Braun Melsungen AG: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2017
  • Table 5.24 B. Braun Melsungen AG: Outpatient Revenue ($million), AGR (%) 2015-2017
  • Table 5.25 B. Braun Melsungen AG: Strategic Developments, 2015-2018
  • Table 5.26 BSN Medical GmbH: Key Facts, 2018
  • Table 5.27 BSN Medical GmbH: Strategic Developments, 2015-2018
  • Table 5.28 Cardinal Health, Inc.: Key Facts, 2019
  • Table 5.29 Cardinal Health, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.30 Cardinal Health, Inc.: Medical Segment Revenue ($million), AGR (%) 2016-2018
  • Table 5.31 Cardinal Health, Inc.: Strategic Developments, 2015-2019
  • Table 5.32 Generex Biotechnology Corp.: Key Facts, 2019
  • Table 5.33 Generex Biotechnology Corp.: Strategic Developments, 2015-2019
  • Table 5.34 Hill-Rom Holdings, Inc.: Key Facts, 2019
  • Table 5.35 Hill-Rom Holdings, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.36 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), AGR (%) 2016-2018
  • Table 5.37 Hill-Rom Holdings, Inc.: Strategic Developments, 2015-2018
  • Table 5.38 Hollister, Inc.: Key Facts, 2018
  • Table 5.39 Integra LifeSciences Holdings Corporation: Key Facts, 2019
  • Table 5.40 Integra LifeSciences Holdings Corporation: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.41 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), AGR (%) 2016-2018
  • Table 5.42 Integra LifeSciences Holdings Corporation: Strategic Developments, 2015-2018
  • Table 5.43 Lohmann & Rauscher GmbH & Co. Kg: Key Facts, 2018
  • Table 5.44 Lohmann & Rauscher GmbH & Co. Kg: Strategic Developments, 2015-2018
  • Table 5.45 Medline Industries, Inc.: Key Facts, 2018
  • Table 5.46 Medtronic PLC: Key Facts, 2018
  • Table 5.47 Medtronic PLC: Revenue ($million) and Revenue Shares (%) by Segment, 2018
  • Table 5.48 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), AGR (%) 2016-2018
  • Table 5.49 Medtronic PLC: Minimally Invasive Product Revenue ($million) and Revenue Shares (%), 2018
  • Table 5.50 Medtronic PLC: Strategic Developments, 2015-2018
  • Table 5.51 Organogenesis Inc.: Key Facts, 2018
  • Table 5.52 Organogenesis Inc.: Strategic Developments, 2015-2018
  • Table 5.53 PAUL HARTMANN AG: Key Facts, 2019
  • Table 5.54 PAUL HARTMANN AG: Revenue ($million) and Revenue Shares (%) by Segment, 2018
  • Table 5.55 PAUL HARTMANN AG: Wound Management Revenue ($million), AGR (%) 2017-2018
  • Table 5.56 Celularity, Inc.: Key Facts, 2019
  • Table 5.57 Celularity, Inc.: Strategic Developments, 2015-2018
  • Table 5.58 Johnson & Johnson: Key Facts, 2019
  • Table 5.59 Johnson & Johnson: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.60 Johnson & Johnson: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.61 Johnson & Johnson: Wound Care/Other Revenue ($million), AGR (%) 2016-2018
  • Table 7.1 Top 20 Companies and Revenue, 2018 ($million)

List of Figures

  • Figure 4.1 Market share of key companies in advanced wound care market (%), 2018
  • Figure 4.2 Global Advanced Wound Care Market Revenue ($bn), 2018-2029
  • Figure 5.1 Smith & Nephew Plc.: Historical Revenues ($million, 2014-2018
  • Figure 5.2 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.3 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.4 Smith & Nephew Plc.: Revenue Shares (%) by Region, 2018
  • Figure 5.5 Smith & Nephew Plc: Advanced Wound Management Revenue ($million), 2016-2018
  • Figure 5.6 Smith & Nephew Plc.: Advanced Wound Management Product Revenue Shares (%), 2018
  • Figure 5.7 Mölnlycke : Historical Revenues ($million), 2014-2018
  • Figure 5.8 ConvaTec Group Plc: Historical Revenues ($million), 2014-2018
  • Figure 5.9 ConvaTec Group Plc: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.10 ConvaTec Group Plc: Revenue Shares (%) by Region, 2018
  • Figure 5.11 ConvaTec Group Plc: Advanced Wound Care Revenue Shares (%), 2016-2018
  • Figure 5.12 Coloplast A/S: Historical Revenues ($million), 2014-2018
  • Figure 5.13 Coloplast A/S: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.14 Coloplast A/S: Revenue Shares (%) by Region, 2018
  • Figure 5.15 Coloplast A/S: Wound & Skin Care Revenue ($million), 2016-2018
  • Figure 5.16 3M Company: Historical Revenues ($million), 2014-2018
  • Figure 5.17 3M Company: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.18 3M Company: Revenue Shares (%) by Region, 2018
  • Figure 5.19 B. Braun Melsungen AG: Historical Revenues ($million), 2013-2017
  • Figure 5.20 B. Braun Melsungen AG: Revenue Shares (%) by Reporting Segment, 2017
  • Figure 5.21 B. Braun Melsungen AG: Revenue Shares (%) by Region, 2017
  • Figure 5.22 B. Braun Melsungen AG: Outpatient Revenue ($million), 2015-2017
  • Figure 5.23 Cardinal Health, Inc.: Historical Revenues ($million), 2014-2018
  • Figure 5.24 Cardinal Health, Inc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.25 Cardinal Health, Inc.: Revenue Shares (%) by Region, 2018
  • Figure 5.26 Cardinal Health, Inc.: Medical Segment Revenue ($million), 2016-2018
  • Figure 5.27 Hill-Rom Holdings, Inc.: Historical Revenues ($million), 2014-2018
  • Figure 5.28 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.29 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Region, 2018
  • Figure 5.30 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), 2016-2018
  • Figure 5.31 Integra LifeSciences Holdings Corporation: Historical Revenues ($million), 2014-2018
  • Figure 5.32 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.33 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Region, 2018
  • Figure 5.34 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), 2016-2018
  • Figure 5.35 Medtronic PLC: Historical Revenues ($million), 2014-2018
  • Figure 5.36 Medtronic PLC: Revenue Shares (%) by Segment, 2018
  • Figure 5.37 Medtronic PLC: Revenue Shares (%) by Product Type, 2018
  • Figure 5.38 Medtronic PLC: Revenue Shares (%) by Region, 2017
  • Figure 5.39 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), 2016-2018
  • Figure 5.40 Medtronic PLC: Minimally Invasive Product Revenue Shares (%), 2018
  • Figure 5.42 PAUL HARTMANN AG: Revenue Shares (%) by Product Type, 2018
  • Figure 5.43 PAUL HARTMANN AG: Revenue Shares (%) by Region, 2018
  • Figure 5.44 PAUL HARTMANN AG: Wound Management Revenue ($million), 2017-2018
  • Figure 5.45 PAUL HARTMANN AG: Wound Management Revenue by Region($million), 2018
  • Figure 5.46 Johnson & Johnson: Historical Revenues ($million), 2014-2018
  • Figure 5.47 Johnson & Johnson: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.48 Johnson & Johnson: Revenue Shares (%) by Product, 2018
  • Figure 5.49 Johnson & Johnson: Revenue Shares (%) by Region, 2018
  • Figure 5.50 Johnson & Johnson: Wound Care/Other Revenue ($million), 2016-2018
  • Figure 5.51 Johnson & Johnson: Wound Care/Other Revenue by Region ($million), 2018
  • Figure 6.1 SWOT Analysis of the Global Advanced Wound Care Market, 2019

List of Companies and Organizations Mentioned in the Report:

  • 3M Company
  • Acelity L.P. Inc.
  • Alliqua BioMedical
  • Avista Capital Partners
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Celularity, Inc.
  • Center for Disease Control (CDC)
  • Codman Neurosurgery
  • Coloplast A/S
  • ConvaTec Group plc
  • Covidien Plc.
  • Crawford Healthcare
  • DeOst group
  • ER Squibb & Sons
  • FarrowMed
  • Food and Drug Administration (FDA)
  • Generex Biotechnology Corp.
  • GHD GesundHeits GMBH Deutschland
  • Healthpoint Biotheraputics
  • Hill-Rom Holdings, Inc.
  • Hollister Incorporated
  • Immodulon
  • Integra LifeSciences Holdings Corporation
  • International Diabetes Federation (IDF)
  • Johnson & Johnson
  • Johnson & Johnson
  • JoViPak
  • KCI
  • Lohmann & Rauscher GmbH & Co. Kg
  • Mediq
  • Medline Industries, Inc.
  • Medtronic PLC
  • Metasurg
  • Ministry of Health, Labour, and Welfare (MHLW)
  • Mölnlycke Health Care
  • Nordic Capital Partners
  • NuTech Medical
  • Olaregen Therapeutix Inc.
  • Organogenesis
  • PAUL HARTMANN AG
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Regentys Corporation
  • SastoMed GmbH.
  • Smith & Nephew
  • SNaP
  • Sorbion
  • Spiracur Inc.
  • Sundance Enterprises, Inc.
  • TEI Biosciences Inc.
  • TEI Medical Inc.
  • Terumo Corporation
  • The Harvard Drug Group (THDG)
  • Tissue Analytics
  • World Health Organisation (WHO)
  • Wright Therapy Products, Inc.
目次
Product Code: PHA0527

The global advanced wound care market was valued at $9.2bn in 2018. The largest segment of the advanced wound care market will continue to be active wound care throughout the forecast period. However, this segment will continue to lose market shares to wound care devices and wound care biologics sectors, from 55.2% in 2019 to 38.9% in 2029.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 129-page report you will receive 121 charts - all unavailable elsewhere.

The 129-page report provides clear detailed insight into the leading 20 companies in the advanced wound care market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Advanced Wound Care Market forecast from 2019-2029

Forecast of the Global Advanced Wound Care Market by region:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • RoW

Our study discusses the selected leading companies that are the major players in the global advanced wound care market:

  • 3M Company
  • Acelity L.P. Inc.
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Celularity, Inc.
  • Coloplast A/S
  • ConvaTec Group plc
  • Generex Biotechnology Corp.
  • Hill-Rom Holdings, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Lohmann & Rauscher GmbH & Co. Kg
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mölnlycke Health Care
  • Organogenesis
  • PAUL HARTMANN AG
  • Smith & Nephew

This report provides a SWOT analysis of the advanced wound care market.

This report also discusses factors that drive and restrain the market, as well as opportunities in the advanced wound care market.

Visiongain's study is intended for anyone requiring commercial analyses for the top 20 advanced wound care companies. You find data, trends and predictions.

Buy our report today Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Overview of the Global Advanced Wound Care Market
  • 1.3 Benefits of This Report
  • 1.4 Report Structure
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to the Advanced Wound Care Market

  • 2.1 Advanced Wound Care Market Definition
    • 2.1.1 Definition of Wound
    • 2.1.2 Types of Wound
  • 2.2 Advanced Wound Care Market Segmentation
    • 2.2.1 Advanced Wound Care Market by Therapy
      • 2.2.1.1 Traditional wound care
      • 2.2.1.2 Advanced Wound Care
    • 2.2.2 Advanced Wound Care Market by Biologics
      • 2.2.2.1 Skin Replacement Therapies
      • 2.2.2.2 Collagen-Based Therapies
      • 2.2.2.3 Cell-Based Therapies
    • 2.2.3 Advanced Wound Care market by Devices
      • 2.2.3.1 Negative Pressure Wound Therapy (NPWT)
      • 2.2.3.2 Ultrasound for Wound Therapy
  • 2.3 Demand for Advanced Wound Care in Regional Markets
    • 2.3.1 Americas Advanced Wound Care Market Overview - 2018
    • 2.3.2 Europe Advanced Wound Care Market Overview- 2018
    • 2.3.3 Asia-Pacific Advanced Wound Care Market 2018

3. Global Advanced Wound Care Market, 2018

  • 3.1 Global Advanced Wound Care Market 2018 Overview
  • 3.2 The World Advanced Wound Care Market: Industry Trends, 2018-2029
  • 3.3 Drivers and Challenges for the Global Advanced Wound Care Market
    • 3.3.1 Drivers
      • 3.3.1.1 Increase in Aging Population:
      • 3.3.1.2 Lifestyle Factors
      • 3.3.1.3 Growing Incidence of Diabetes, Ulcers and Chronic Wounds
      • 3.3.1.4 Technological Advancements and Government Initiatives
    • 3.3.2 Challenges
      • 3.3.2.1 High Cost Procedures
      • 3.3.2.2 Disparity in Reimbursements
      • 3.3.2.3 Reluctance to Accept New Technologies
    • 3.3.3 Opportunities
      • 3.3.3.1 Significant Growth Opportunities in Asia-Pacific and Developing Countries
      • 3.3.3.2 Healthy Growth in the Active Wound Care Market

4. Leading 20 Companies Positioning in the Advanced Wound Care Market

  • 4.1 Leading 20 Companies Ranking in the Advanced Wound Care Market
  • 4.2 Global Advanced Wound Care Market Forecast, 2018-2029

5. Top 20 Advanced Wound Care Companies

  • 5.1 Smith & Nephew Plc. Overview
    • 5.1.1 Smith & Nephew Plc. Financial Outlook
    • 5.1.2 Smith & Nephew Plc Product Portfolio
    • 5.1.3 Smith & Nephew Plc Strategic Developments
  • 5.2 Acelity (KCI and Systagenix) Overview
    • 5.2.1 Acelity L.P. Inc. Financial Outlook
    • 5.2.2 Acelity L.P. Inc. Product Portfolio
    • 5.2.3 Acelity L.P. Inc. Strategic Developments
  • 5.3 Mölnlycke Health Care AB Overview
    • 5.3.1 Mölnlycke Financial Outlook
    • 5.3.2 Mölnlycke Product Portfolio
    • 5.3.3 Mölnlycke Strategic Developments
  • 5.4 ConvaTec Group Plc Overview
    • 5.4.1 ConvaTec Group Plc Financial Outlook
    • 5.4.2 ConvaTec Group Plc Product Portfolio
    • 5.4.3 ConvaTec Group Plc Strategic Developments
  • 5.5 Coloplast A/S Overview
    • 5.5.1 Coloplast A/S Financial Outlook
    • 5.5.2 Coloplast A/S Product Portfolio
    • 5.5.3 Coloplast A/S Strategic Developments
  • 5.6 3M Company Overview
  • 5.6. 3M Company Financial Outlook
    • 5.6.2 3M Company Product Portfolio
    • 5.6.3 3M Company Strategic Developments
  • 5.7 B. Braun Melsungen AG Overview
    • 5.7.1 B. Braun Melsungen AG Financial Outlook
    • 5.7.2 B. Braun Melsungen AG Product Portfolio
    • 5.7.3 B. Braun Melsungen AG Strategic Developments
  • 5.8 BSN Medical GmbH Overview
    • 5.8.1 BSN Medical GmbH Financial Outlook
    • 5.8.2 BSN Medical GmbH Product Portfolio
    • 5.8.3 BSN Medical GmbH Strategic Developments
  • 5.9 Cardinal Health, Inc. Overview
    • 5.9.1 Cardinal Health, Inc. Financial Outlook
    • 5.9.2 Cardinal Health, Inc. Product Portfolio
    • 5.9.3 Cardinal Health, Inc. Strategic Developments
  • 5.10 Generex Biotechnology Corp. Overview
    • 5.10.1 Generex Biotechnology Corp.Financial Outlook
    • 5.10.2 Generex Biotechnology Corp. Product Portfolio
    • 5.10.3 Generex Biotechnology Corp. Strategic Developments
  • 5.11 Hill-Rom Holdings, Inc. Overview
    • 5.11.1 Hill-Rom Holdings, Inc.Financial Outlook
    • 5.9.2 Hill-Rom Holdings, Inc. Product Portfolio
  • 5.11.3 Hill-Rom Holdings, Inc. Strategic Developments
  • 5.12 Hollister, Inc. Overview
    • 5.12.1 Hollister, Inc. Financial Outlook
    • 5.12.2 Hollister, Inc. Product Portfolio
  • 5.13 Integra LifeSciences Holdings Corporation Overview
    • 5.13.1 Integra LifeSciences Holdings Corporation Financial Outlook
    • 5.9.2 Integra LifeSciences Holdings Corporation Product Portfolio
    • 5.13.3 Integra LifeSciences Holdings Corporation Strategic Developments
  • 5.14 Lohmann & Rauscher GmbH & Co. Kg Overview
    • 5.14.1 Lohmann & Rauscher GmbH & Co. Kg Financial Outlook
    • 5.14.2 Lohmann & Rauscher GmbH & Co. Kg Product Portfolio
    • 5.14.3 Lohmann & Rauscher GmbH & Co. Kg Strategic Developments
  • 5.15 Medline Industries, Inc. Overview
    • 5.15.1 Medline Industries, Inc. Financial Outlook
    • 5.15.2 Medline Industries, Inc. Product Portfolio
  • 5.16 Medtronic PLC Overview
    • 5.16.1 Medtronic PLC Financial Outlook
    • 5.16.2 Medtronic PLC Product Portfolio
    • 5.16.3 Medtronic PLC Strategic Developments
  • 5.17 Organogenesis Inc. Overview
    • 5.17.1 Organogenesis Inc.Financial Outlook
    • 5.17.2 Organogenesis Inc. Product Portfolio
    • 5.17.3 Organogenesis Inc. Strategic Developments
  • 5.18 PAUL HARTMANN AG Overview
    • 5.18.1 PAUL HARTMANN AG Financial Outlook
    • 5.18.2 PAUL HARTMANN AG Product Portfolio
  • 5.19 Celularity, Inc.Overview
    • 5.19.1 Celularity, Inc. Financial Outlook
    • 5.19.2 Celularity, Inc. Product Portfolio
    • 5.19.3 Celularity, Inc. Strategic Developments
  • 5.20 Johnson & Johnson Overview
    • 5.20.1 Johnson & Johnson Financial Outlook
    • 5.5.2 Johnson & Johnson Product Portfolio

6 SWOT Analysis of the Global Advanced Wound Care Market

  • 6.1 Strengths
  • 6.2 Weaknesses
  • 6.3 Opportunities
  • 6.4 Threats

7. Conclusion

  • 7.1 Continuous Innovation and a Strong R&D Pipeline
  • 7.2 Higher Effectiveness Compared with Other Treatments
  • 7.3 An Oligopolistic Market
  • 7.4 Top 20 Companies and Revenue

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form
Back to Top